Improved Aerobic Capacity and Adipokine Profile Together with Weight Loss Improve Glycemic Control without Changes in Skeletal Muscle GLUT-4 Gene Expression in Middle-Aged Subjects with Impaired Glucose Tolerance

Int J Environ Res Public Health. 2022 Jul 7;19(14):8327. doi: 10.3390/ijerph19148327.

Abstract

(1) Objective: The aim of this study was to clarify the role of adipokines in the regulation of glucose metabolism in middle-aged obese subjects with impaired glucose tolerance in response to a long-term exercise and dietary intervention. (2) Methods: Skeletal muscle, plasma and serum samples were examined in 22 subjects from an exercise−diet intervention study aiming to prevent type 2 diabetes. The subjects were further divided into two subgroups (non-responders n = 9 and responders n = 13) based on their achievement in losing at least 3 kg. (3) Results: The two-year exercise−diet intervention reduced leptin levels and increased adiponectin levels in responders; the changes in leptin levels were significantly associated with changes in their weights (r = 0.662, p < 0.01). In responders, insulin sensitivity (Bennett and McAuley index) increased and was associated with changes in maximal oxygen uptake (VO2peak) (r = 0.831, p < 0.010 and r = 0.890, p < 0.01). In addition, the VO2peak and oxidative capacity of skeletal muscle improved in responders, but not in non-responders. However, there were no changes between the two groups in expressions of the glucose transporter protein-4 (GLUT-4) gene or of AMP-activated protein kinase (AMPK)-α1 or AMPK-α2 proteins. (4) Conclusions: The exercise−diet intervention decreased serum leptin and increased serum adiponectin concentrations, improved glucose control without affecting GLUT-4 gene expression in the skeletal muscle in responders.

Keywords: adipokines; aerobic capacity; glycemic control; impaired glucose tolerance; physical activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / genetics
  • AMP-Activated Protein Kinases / metabolism
  • Adipokines
  • Adiponectin
  • Blood Glucose / metabolism
  • Diabetes Mellitus, Type 2*
  • Gene Expression
  • Glucose Intolerance*
  • Glucose Transporter Type 4 / metabolism*
  • Glycemic Control
  • Humans
  • Insulin Resistance*
  • Leptin
  • Middle Aged
  • Muscle, Skeletal / metabolism
  • Weight Loss

Substances

  • Adipokines
  • Adiponectin
  • Blood Glucose
  • Glucose Transporter Type 4
  • Leptin
  • SLC2A4 protein, human
  • AMP-Activated Protein Kinases

Grants and funding

Research Council for Physical Education and Sports, the Finnish Ministry of Education, the Juho Vainio Foundation, Turku University of Applied Sciences R&D program and the COST Action CA16112.